These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13200493)

  • 21. The effect of lysergic acid diethylamide on Betta splendens. II. Frenquel.
    TURNER WJ
    Dis Nerv Syst; 1956 Jun; 17(6):198. PubMed ID: 13330612
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of lysergic acid diethylamide upon performance of trained rats.
    WINTER CA; FLATAKER L
    Proc Soc Exp Biol Med; 1956 Jun; 92(2):285-9. PubMed ID: 13350323
    [No Abstract]   [Full Text] [Related]  

  • 23. Some effects of bufotenine and lysergic acid diethylamide on the monkey.
    EVARTS EV
    AMA Arch Neurol Psychiatry; 1956 Jan; 75(1):49-53. PubMed ID: 13275159
    [No Abstract]   [Full Text] [Related]  

  • 24. THE METABOLITES OF ERGOMETRINE AND LYSERGIC ACID DIETHYLAMIDE IN RAT BILE.
    SLAYTOR MB; WRIGHT SE
    J Med Pharm Chem; 1962 May; 5():483-91. PubMed ID: 14056385
    [No Abstract]   [Full Text] [Related]  

  • 25. Further observations on the effects of lysergic acid diethylamide.
    MAYER-GROSS W; McADAM W; WALKER JW
    J Ment Sci; 1953 Oct; 99(417):804-8. PubMed ID: 13109462
    [No Abstract]   [Full Text] [Related]  

  • 26. Some vascular actions of 1-methyl-d-lysergic acid butanolamide with special reference to its reflex-blocking and antiserotonin actions.
    GEBBER GL; BECK L
    Med Bull (Ann Arbor); 1963; 29():182-94. PubMed ID: 13946952
    [No Abstract]   [Full Text] [Related]  

  • 27. Biogenesis of lysergic acid in ergot.
    TAYLOR EH; RAMSTAD E
    Nature; 1960 Nov; 188():494-5. PubMed ID: 13775580
    [No Abstract]   [Full Text] [Related]  

  • 28. [D-lysergic acid diethylamine and psychic disorders in ergotism].
    DELAY J; PICHOT P
    C R Seances Soc Biol Fil; 1951 Nov; 145(21-22):1609-10. PubMed ID: 14926207
    [No Abstract]   [Full Text] [Related]  

  • 29. Dissociation constants of some compounds related to lysergic acid. II. Ergometrine, ergometrinine and alkanolamides of 3-dimethylaminopropionic acid, 1-methylhexahydronicotinic acid and arecaidine.
    CHILTON J; STENLAKE JB
    J Pharm Pharmacol; 1962 Jun; 14():367-70. PubMed ID: 13878985
    [No Abstract]   [Full Text] [Related]  

  • 30. Dissociation constants of some compounds related to lysergic acid; Beta-dimethylaminopropionic acid, dihydroarecaidine, ecgonine and their derivatives.
    CHILTON J; STENLAKE JB
    J Pharm Pharmacol; 1955 Dec; 7(12):1004-11. PubMed ID: 13278846
    [No Abstract]   [Full Text] [Related]  

  • 31. [About Curtius degradation of the isomeric lysergic and dihydrolysergic acids; 12th report on ergot alkaloids].
    HOFMANN A
    Helv Chim Acta; 1947 Feb; 30(1):44-51. PubMed ID: 20294131
    [No Abstract]   [Full Text] [Related]  

  • 32. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE
    S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429
    [No Abstract]   [Full Text] [Related]  

  • 33. [Isolation of alkaloids from domestic ergot].
    KUCZYNSKI L; ZAWISZA T
    Acta Pol Pharm; 1955; 11(Suppl):85-9. PubMed ID: 13248647
    [No Abstract]   [Full Text] [Related]  

  • 34. Model psychoses induced by LSD-25 in normals. II. Rorschach test findings.
    BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):612-8. PubMed ID: 13325990
    [No Abstract]   [Full Text] [Related]  

  • 35. Ergot alkaloids: synthetic approaches to lysergic acid and clavine alkaloids.
    Liu H; Jia Y
    Nat Prod Rep; 2017 Apr; 34(4):411-432. PubMed ID: 28300233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction.
    BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989
    [No Abstract]   [Full Text] [Related]  

  • 37. [Extraction of water soluble ergot alkaloids from the drug and from aqueous solutions].
    GALFI M; MOLNAR I; REITZER SS
    Pharmazie; 1956 Aug; 11(8):548-51. PubMed ID: 13378989
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ergot alkaloids. IV. Estimation of alkaloids in a single sclerotium by means of paper chromatography].
    MACEK K; VANECEK S
    Pharmazie; 1955 Jul; 10(7):422-9. PubMed ID: 13280333
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemical structure of ergot alkaloids. II. Lizerg acid, ergin, ergometrine].
    BAYER I
    Gyogyszeresz; 1951 Sep; 6(9):210-1. PubMed ID: 24541810
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alkaloid content of ergot growing naturally in Germany during 1951].
    SILBER A
    Pharmazie; 1952 Dec; 7(12):854-9. PubMed ID: 13100054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.